Study protocol of the TIRED study: a randomised controlled trial comparing either graded exercise therapy for severe fatigue or cognitive behaviour therapy with usual care in patients with incurable cancer

Hanneke Poort, Constans A H H V M Verhagen, Marlies E W J Peters, Martine M Goedendorp, A Rogier T Donders, Maria T E Hopman, Maria W G Nijhuis-van der Sanden, Thea Berends, Gijs Bleijenberg, Hans Knoop, Hanneke Poort, Constans A H H V M Verhagen, Marlies E W J Peters, Martine M Goedendorp, A Rogier T Donders, Maria T E Hopman, Maria W G Nijhuis-van der Sanden, Thea Berends, Gijs Bleijenberg, Hans Knoop

Abstract

Background: Fatigue is a common and debilitating symptom for patients with incurable cancer receiving systemic treatment with palliative intent. There is evidence that non-pharmacological interventions such as graded exercise therapy (GET) or cognitive behaviour therapy (CBT) reduce cancer-related fatigue in disease-free cancer patients and in patients receiving treatment with curative intent. These interventions may also result in a reduction of fatigue in patients receiving treatment with palliative intent, by improving physical fitness (GET) or changing fatigue-related cognitions and behaviour (CBT). The primary aim of our study is to assess the efficacy of GET or CBT compared to usual care (UC) in reducing fatigue in patients with incurable cancer.

Methods: The TIRED study is a multicentre three-armed randomised controlled trial (RCT) for incurable cancer patients receiving systemic treatment with palliative intent. Participants will be randomised to GET, CBT, or UC. In addition to UC, the GET group will participate in a 12-week supervised exercise programme. The CBT group will receive a 12-week CBT intervention in addition to UC. Primary and secondary outcome measures will be assessed at baseline, post-intervention (14 weeks), and at follow-up assessments (18 and 26 weeks post-randomisation). The primary outcome measure is fatigue severity (Checklist Individual Strength subscale fatigue severity). Secondary outcome measures are fatigue (EORTC-QLQ-C30 subscale fatigue), functional impairments (Sickness Impact Profile total score, EORTC-QLQ-C30 subscale emotional functioning, subscale physical functioning) and quality of life (EORTC-QLQ-C30 subscale QoL). Outcomes at 14 weeks (primary endpoint) of either treatment arm will be compared to those of UC participants. In addition, outcomes at 18 and 26 weeks (follow-up assessments) of either treatment arm will be compared to those of UC participants.

Discussion: To our knowledge, the TIRED study is the first RCT investigating the efficacy of GET and CBT on reducing fatigue during treatment with palliative intent in incurable cancer patients. The results of this study will provide information about the possibility and efficacy of GET and CBT for severely fatigued incurable cancer patients.

Trial registration: NTR3812 ; date of registration: 23/01/2013.

Keywords: Advanced cancer; Cognitive behaviour therapy; Fatigue; Graded exercise therapy; Randomised controlled trial.

Figures

Fig. 1
Fig. 1
Flowchart of the TIRED study

References

    1. Global Burden of Disease Cancer C. Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M, MacIntyre MF, Allen C, Hansen G, Woodbrook R, et al. The Global Burden of Cancer 2013. JAMA Oncol. 2015;1:505–27. doi: 10.1001/jamaoncol.2015.0735.
    1. Sepulveda C, Marlin A, Yoshida T, Ullrich A. Palliative Care: the World Health Organization's global perspective. J Pain Symptom Manage. 2002;24:91–6. doi: 10.1016/S0885-3924(02)00440-2.
    1. Butt Z, Rosenbloom SK, Abernethy AP, Beaumont JL, Paul D, Hampton D, Jacobsen PB, Syrjala KL, Von Roenn JH, Cella D. Fatigue is the most important symptom for advanced cancer patients who have had chemotherapy. J Natl Compr Canc Netw. 2008;6:448–55.
    1. Hauser K, Walsh D, Rybicki LA, Davis MP, Seyidova-Khoshknabi D. Fatigue in advanced cancer: a prospective study. Am J Hosp Palliat Care. 2008;25:372–8. doi: 10.1177/1049909108319267.
    1. Radbruch L, Strasser F, Elsner F, Goncalves JF, Loge J, Kaasa S, Nauck F, Stone P. Research Steering Committee of the European Association for Palliative C: Fatigue in palliative care patients -- an EAPC approach. Palliat Med. 2008;22:13–32. doi: 10.1177/0269216307085183.
    1. Echteld MA, Passchier J, Teunissen S, Claessen S, de Wit R, van der Rijt CC. Multidimensional fatigue and its correlates in hospitalised advanced cancer patients. Eur J Cancer. 2007;43:1030–6. doi: 10.1016/j.ejca.2007.01.024.
    1. Stone PC, Minton O. Cancer-related fatigue. Eur J Cancer. 2008;44:1097–104. doi: 10.1016/j.ejca.2008.02.037.
    1. Network NCC . NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Cancer-Related Fatigue. 2016.
    1. Paiva CE, Paiva BS. Prevalence, predictors, and prognostic impact of fatigue among Brazilian outpatients with advanced cancers. Support Care Cancer. 2013;21:1053–60. doi: 10.1007/s00520-012-1625-2.
    1. Hofman M, Ryan JL, Figueroa-Moseley CD, Jean-Pierre P, Morrow GR. Cancer-related fatigue: the scale of the problem. Oncologist. 2007;12(Suppl 1):4–10. doi: 10.1634/theoncologist.12-S1-4.
    1. Tanaka K, Akechi T, Okuyama T, Nishiwaki Y, Uchitomi Y. Impact of dyspnea, pain, and fatigue on daily life activities in ambulatory patients with advanced lung cancer. J Pain Symptom Manage. 2002;23:417–23. doi: 10.1016/S0885-3924(02)00376-7.
    1. Peters ME, Goedendorp MM, Verhagen SA, van der Graaf WT, Bleijenberg G. Exploring the contribution of psychosocial factors to fatigue in patients with advanced incurable cancer. Psychooncology. 2014;23:773–9. doi: 10.1002/pon.3481.
    1. Mucke M, Mochamat, Cuhls H, Peuckmann-Post V, Minton O, Stone P, Radbruch L. Pharmacological treatments for fatigue associated with palliative care. Cochrane Database Syst Rev. 2015;5:CD006788.
    1. Dimeo FC. Effects of exercise on cancer-related fatigue. Cancer. 2001;92:1689–93. doi: 10.1002/1097-0142(20010915)92:6+<1689::AID-CNCR1498>;2-H.
    1. Cramp F, Byron-Daniel J. Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev. 2012;11
    1. Lowe SS, Watanabe SM, Courneya KS. Physical activity as a supportive care intervention in palliative cancer patients: a systematic review. J Support Oncol. 2009;7:27–34.
    1. Hagelin CL, Wengstrom Y, Ahsberg E, Furst CJ. Fatigue dimensions in patients with advanced cancer in relation to time of survival and quality of life. Palliat Med. 2009;23:171–8. doi: 10.1177/0269216308098794.
    1. Oldervoll LM, Loge JH, Paltiel H, Asp MB, Vidvei U, Wiken AN, Hjermstad MJ, Kaasa S. The effect of a physical exercise program in palliative care: A phase II study. J Pain Symptom Manage. 2006;31:421–30. doi: 10.1016/j.jpainsymman.2005.10.004.
    1. Porock D, Kristjanson LJ, Tinnelly K, Duke T, Blight J. An exercise intervention for advanced cancer patients experiencing fatigue: a pilot study. J Palliat Care. 2000;16:30–6.
    1. van den Dungen IA, Verhagen CA, van der Graaf WT, van den Berg JP, Vissers KC, Engels Y. Feasibility and impact of a physical exercise program in patients with advanced cancer: a pilot study. J Palliat Med. 2014;17:1091–8. doi: 10.1089/jpm.2013.0638.
    1. Jacobsen PB, Donovan KA, Vadaparampil ST, Small BJ. Systematic review and meta-analysis of psychological and activity-based interventions for cancer-related fatigue. Health Psychol. 2007;26:660–7. doi: 10.1037/0278-6133.26.6.660.
    1. Kangas M, Bovbjerg DH, Montgomery GH. Cancer-related fatigue: a systematic and meta-analytic review of non-pharmacological therapies for cancer patients. Psychol Bull. 2008;134:700–41. doi: 10.1037/a0012825.
    1. Gielissen MF, Verhagen S, Witjes F, Bleijenberg G. Effects of cognitive behavior therapy in severely fatigued disease-free cancer patients compared with patients waiting for cognitive behavior therapy: a randomized controlled trial. J Clin Oncol. 2006;24:4882–7. doi: 10.1200/JCO.2006.06.8270.
    1. Prinsen H, van Dijk JP, Zwarts MJ, Leer JW, Bleijenberg G, van Laarhoven HW. The role of central and peripheral muscle fatigue in postcancer fatigue: a randomized controlled trial. J Pain Symptom Manage. 2015;49:173–82. doi: 10.1016/j.jpainsymman.2014.06.020.
    1. Servaes P, Verhagen S, Bleijenberg G. Determinants of chronic fatigue in disease-free breast cancer patients: a cross-sectional study. Ann Oncol. 2002;13:589–98. doi: 10.1093/annonc/mdf082.
    1. Gielissen M, Verhagen C, Bleijenberg G. Cognitive behaviour therapy for fatigued cancer survivors: long-term follow-up. Br J Cancer. 2007;97:612–8. doi: 10.1038/sj.bjc.6603899.
    1. Goedendorp MM, Peters ME, Gielissen MF, Witjes JA, Leer JW, Verhagen CA, Bleijenberg G. Is increasing physical activity necessary to diminish fatigue during cancer treatment? Comparing cognitive behavior therapy and a brief nursing intervention with usual care in a multicenter randomized controlled trial. Oncologist. 2010;15:1122–32. doi: 10.1634/theoncologist.2010-0092.
    1. Goedendorp MM, Gielissen MF, Peters ME, Verhagen CA, Bleijenberg G. Moderators and long-term effectiveness of cognitive behaviour therapy for fatigue during cancer treatment. Psychooncology. 2012;21:877–85. doi: 10.1002/pon.1981.
    1. Armes J, Chalder T, Addington-Hall J, Richardson A, Hotopf M. A randomized controlled trial to evaluate the effectiveness of a brief, behaviorally oriented intervention for cancer-related fatigue. Cancer. 2007;110:1385–95. doi: 10.1002/cncr.22923.
    1. Ream E, Richardson A, Alexander-Dann C. Supportive intervention for fatigue in patients undergoing chemotherapy: a randomized controlled trial. J Pain Symptom Manag. 2006;31:148–61. doi: 10.1016/j.jpainsymman.2005.07.003.
    1. Davis MP, Khoshknabi D, Yue GH. Management of fatigue in cancer patients. Curr Pain Headache Rep. 2006;10:260–9. doi: 10.1007/s11916-006-0030-2.
    1. Frazier PA, Tix AP, Barron KE. Testing moderator and mediator effects in counseling psychology research. J Couns Psychol. 2004;51:115–134. doi: 10.1037/0022-0167.51.1.115.
    1. Vercoulen JH, Swanink CM, Fennis JF, Galama JM, van der Meer JW, Bleijenberg G. Dimensional assessment of chronic fatigue syndrome. J Psychosom Res. 1994;38:383–92. doi: 10.1016/0022-3999(94)90099-X.
    1. Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14:377–81.
    1. Staal JB, Hlobil H, Koke AJ, Twisk JW, Smid T, van Mechelen W. Graded activity for workers with low back pain: who benefits most and how does it work? Arthritis Rheum. 2008;59:642–9. doi: 10.1002/art.23570.
    1. Oncoline: Cancer Clinincal Practice Guidelines. (2016). Accessed 27 Jun 2016.
    1. Beurskens AJ, Bultmann U, Kant I, Vercoulen JH, Bleijenberg G, Swaen GM. Fatigue among working people: validity of a questionnaire measure. Occup Environ Med. 2000;57(5):353–7.
    1. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–76. doi: 10.1093/jnci/85.5.365.
    1. Aaronson NK, Bullinger M, Ahmedzai S. A modular approach to quality-of-life assessment in cancer clinical trials. Recent Results Cancer Res. 1988;111:231–49. doi: 10.1007/978-3-642-83419-6_27.
    1. Kaasa S, Loge JH. Quality-of-life assessment in palliative care. Lancet Oncol. 2002;3:175–82. doi: 10.1016/S1470-2045(02)00682-4.
    1. Bergner M, Bobbitt RA, Carter WB, Gilson BS. The Sickness Impact Profile: development and final revision of a health status measure. Med Care. 1981;19:787–805. doi: 10.1097/00005650-198108000-00001.
    1. de Bruin AF, de Witte LP, Stevens F, Diederiks JP. Sickness Impact Profile: the state of the art of a generic functional status measure. Soc Sci Med. 1992;35:1003–14. doi: 10.1016/0277-9536(92)90240-Q.
    1. Montoye HJ, Washburn R, Servais S, Ertl A, Webster JG, Nagle FJ. Estimation of energy expenditure by a portable accelerometer. Med Sci Sports Exerc. 1983;15:403–7. doi: 10.1249/00005768-198315050-00010.
    1. Du H, Newton PJ, Salamonson Y, Carrieri-Kohlman VL, Davidson PM. A review of the six-minute walk test: its implication as a self-administered assessment tool. Eur J Cardiovasc Nurs. 2009;8:2–8. doi: 10.1016/j.ejcnurse.2008.07.001.
    1. Jacobsen PB, Andrykowski MA, Thors CL. Relationship of catastrophizing to fatigue among women receiving treatment for breast cancer. J Consult Clin Psychol. 2004;72:355–61. doi: 10.1037/0022-006X.72.2.355.
    1. Borm GF, Fransen J, Lemmens WA. A simple sample size formula for analysis of covariance in randomized clinical trials. J Clin Epidemiol. 2007;60:1234–8. doi: 10.1016/j.jclinepi.2007.02.006.
    1. Van Breukelen GJ. ANCOVA versus change from baseline: more power in randomized studies, more bias in nonrandomized studies [corrected] J Clin Epidemiol. 2006;59:920–5. doi: 10.1016/j.jclinepi.2006.02.007.
    1. Preacher KJ, Hayes AF. Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav Res Methods. 2008;40:879–91. doi: 10.3758/BRM.40.3.879.
    1. White C, Gilshenan K, Hardy J. A survey of the views of palliative care healthcare professionals towards referring cancer patients to participate in randomized controlled trials in palliative care. Support Care Cancer. 2008;16:1397–405. doi: 10.1007/s00520-008-0441-1.
    1. Kars MC, van Thiel GJ, van der Graaf R, Moors M, de Graeff A, van Delden JJ. A systematic review of reasons for gatekeeping in palliative care research. Palliat Med. 2016;30(6):533–48. doi: 10.1177/0269216315616759.
    1. Poort H, Peters ME, Verhagen SA, Verhoeven J, van der Graaf WT, Knoop H. Time to practice what we preach? Appreciating the autonomy of cancer patients on deciding whether they want to be informed about interventional studies for fatigue. Palliat Med. 2016;30(9):897–8. doi: 10.1177/0269216316648070.
    1. Derogatis LR. Handbook of psychiatric measures. Arlington: American Psychiatric Association; 2000. Symptom Checklist-90-Revised; pp. 81–4.
    1. Brom D, Kleber R. De Schok Verwerkings Lijst. Ned Tijdschr Psychol. 1985;40:164–8.
    1. Gielissen MF, Prins JB, Knoop H, Verhagen S, Bleijenberg G. Pictorial Representation of Self and Illness Measure (PRISM): a graphic instrument to assess suffering in fatigued cancer survivors. Psychol Assess. 2013;25:658–63. doi: 10.1037/a0031526.
    1. Evers AW, Kraaimaat FW, van Lankveld W, Jongen PJ, Jacobs JW, Bijlsma JW. Beyond unfavorable thinking: the illness cognition questionnaire for chronic diseases. J Consult Clin Psychol. 2001;69:1026–36. doi: 10.1037/0022-006X.69.6.1026.
    1. Lauwerier E, Crombez G, Van Damme S, Goubert L, Vogelaers D, Evers AW. The construct validity of the illness cognition questionnaire: the robustness of the three-factor structure across patients with chronic pain and chronic fatigue. Int J Behav Med. 2010;17:90–6. doi: 10.1007/s12529-009-9059-z.
    1. Beck AT, Guth D, Steer RA, Ball R. Screening for major depression disorders in medical inpatients with the Beck Depression Inventory for Primary Care. Behav Res Ther. 1997;35:785–91. doi: 10.1016/S0005-7967(97)00025-9.
    1. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67:361–70. doi: 10.1111/j.1600-0447.1983.tb09716.x.
    1. Prins JB, Bleijenberg G, Bazelmans E, Elving LD, de Boo TM, Severens JL, van der Wilt GJ, Spinhoven P, van der Meer JW. Cognitive behaviour therapy for chronic fatigue syndrome: a multicentre randomised controlled trial. Lancet. 2001;357:841–7. doi: 10.1016/S0140-6736(00)04198-2.
    1. Ray C, Weir W, Stewart D, Miller P, Hyde G. Ways of Coping with Chronic Fatigue Syndrome - Development of an Illness Management Questionnaire. Soc Sci Med. 1993;37:385–91. doi: 10.1016/0277-9536(93)90268-9.
    1. Timmerman IGH, Emanuels-Zuurveen ES, Emmelkamp PMG. The Social Support Inventory (SSI): A brief scale to assess perceived adequacy of social support. Clin Psychol Psychother. 2000;7:401–10. doi: 10.1002/1099-0879(200011)7:5<401::AID-CPP253>;2-I.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe